Clearstead Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$146K Buy
959
+848
+764% +$141K ﹤0.01% 1155
2026
Q1
$23.3K Sell
111
-634
-85% -$159K ﹤0.01% 1421
2025
Q4
$212K Buy
745
+497
+200% +$155K ﹤0.01% 927
2025
Q3
$76.6K Buy
248
+27
+12% +$8.46K ﹤0.01% 1143
2025
Q2
$69.4K Buy
221
+190
+613% +$54.8K ﹤0.01% 1178
2025
Q1
$8.14K Sell
31
-27
-47% -$7.31K ﹤0.01% 1663
2024
Q4
$15.1K Sell
58
-332
-85% -$83.6K ﹤0.01% 1468
2024
Q3
$90.8K Buy
390
+80
+26% +$16.4K ﹤0.01% 1052
2024
Q2
$62.6K Buy
310
+58
+23% +$10.5K ﹤0.01% 1116
2024
Q1
$40.6K Sell
252
-148
-37% -$27.6K ﹤0.01% 815
2023
Q4
$86.8K Sell
400
-112
-22% -$19.2K ﹤0.01% 616
2023
Q3
$81.7K Buy
512
+49
+11% +$11K 0.01% 600
2023
Q2
$134K Buy
463
+318
+219% +$96.6K 0.01% 509
2023
Q1
$46.3K Buy
145
+123
+559% +$36.5K ﹤0.01% 675
2022
Q4
$6.48K Buy
+22
New +$6.07K ﹤0.01% 958

Other funds holding PODD

Clearstead Advisors's PODD Position: Q2 2026 in Review

Clearstead Advisors increased its Insulet (PODD) stake by 764% in Q2 2026, buying an estimated $141K and bringing the position to 959 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #1155.

Clearstead Advisors first reported a position in PODD in Q4 2022 and has held it in 15 quarters since. The position peaked at $212K in Q4 2025. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Clearstead Advisors held 959 shares of Insulet worth $146K as of Q2 2026.
  • Clearstead Advisors bought 848 Insulet shares in Q2 2026, an estimated $141K.
  • Insulet made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1155 holding.
  • Clearstead Advisors first reported a position in Insulet in Q4 2022 and has held it in 15 quarters since.
  • Clearstead Advisors's Insulet position peaked at $212K in Q4 2025.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.